No Data
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Earnings Preview: Regenxbio to Report Financial Results Post-market on November 06
$Regenxbio(RGNX.US)$ is scheduled to release its financial results post-market on November 06 ET. Earnings PreviewAnalysts estimate $Regenxbio(RGNX.US)$ to post revenue of USD24.40M for 2024Q3, down 1
REGENXBIO to Host Conference Call on November 6 to Discuss Third Quarter 2024 Financial Results and Recent Operational Highlights
REGENXBIO (NASDAQ:RGNX Shareholders Incur Further Losses as Stock Declines 9.6% This Week, Taking Three-year Losses to 74%
The Past Five Years for REGENXBIO (NASDAQ:RGNX) Investors Has Not Been Profitable
REGENXBIO Is Maintained at Buy by Chardan Capital
No Data
No Data